DODIE KIRKENDOLL: Open Payments
NPI 1881846509 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$649 in 36 payments from 12 companies in 2025. Trend: 2023 $575 · 2024 $1,174 · 2025 $649
Food & beverage: $649
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $146 |
| Merck Sharp & Dohme LLC | 7 | $128 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 6 | $103 |
| SCPHARMACEUTICALS INC. | 2 | $62 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $25 |
| Boston Scientific Corporation | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $19 |
Products named: VERQUVO, LifeVest, CAMZYOS, ELIQUIS, FUROSCIX, LEQVIO, FARXIGA, XIFAXAN.
Industry payments across KY — which companies pay providers there.
